We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.50 | -0.37% | 1,749.50 | 1,749.50 | 1,750.00 | 1,759.00 | 1,740.50 | 1,743.50 | 809,796 | 13:14:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.67 | 72.32B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/4/2020 12:10 | Christh, most stocks are up at least 5%. these are doing nothing, AV up 13.8% at the moment. | igoe104 | |
07/4/2020 12:06 | montyhedge7 Apr '20 - 10:19 - 21079 of 21084 Shareprice going nowhere. its up you idiot | christh | |
07/4/2020 11:09 | Thursday I think you'll find igoe. spud | spud | |
07/4/2020 11:09 | I don't know how many posters follow the presentation and disclosure of R&D costs here. Ex 1 - costs of R&D in their own labs. Ex 2a - buy in of a third party's R&D from a listed company. Ex 2b - buy in of a third party's R&D from a non listed company. Huge numbers. | alphorn | |
07/4/2020 11:07 | 23p dividend this Friday. | igoe104 | |
07/4/2020 10:53 | Still 20% down over the last couple of months. Azn less than 10% down. | igoe104 | |
07/4/2020 10:50 | A bit dull and defensive this one - my largest holding.Good and reassuring in down days but always a bit of a let down when market flying | watfordhornet | |
07/4/2020 10:19 | Shareprice going nowhere. | montyhedge | |
07/4/2020 09:35 | Vir market capitalisation is $4.03 bn | tradermichael | |
07/4/2020 08:46 | What share of VIR will 250m give GSK? | watfordhornet | |
07/4/2020 08:41 | GlaxoSmithKline PLC said Monday that it will invest $250 million in Vir Biotechnology Inc. as part of their new partnership to research and develop solutions for the treatment of coronaviruses, including the one that causes Covid-19. The British pharma group said the collaboration will use Vir's proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used to treat coronaviruses, while GlaxoSmithKline will provide expertise in functional genomics. GlaxoSmithKline said that to gain access to Vir's technology, it will buy Vir's shares at $37.73, a 10% premium to the closing share price on Friday. | tradermichael | |
06/4/2020 17:43 | great news for us all. | barony | |
06/4/2020 15:12 | Over 1500p can't hold bears and profit takers pile in. | montyhedge | |
03/4/2020 16:46 | Or cash which is still king | bc4 | |
03/4/2020 16:31 | buywell, if the world does have to press the reset button, it is probably best to be owning cash generating assets (and probably some gold tucked away in your back pocket) | crazycoops | |
03/4/2020 11:16 | Interesting link - Chinese company that launched the first Hep E vaccine. The further the net is cast the greater the probability of finding something. | alphorn | |
03/4/2020 11:09 | GSK To Collaborate With Xiamen Innovax Biotech To Evaluate Recombinant Protein-Based Coronavirus Vaccine Candidate – RTRS | zho | |
03/4/2020 03:37 | Problem is IMO after Covid-19 what Health Services in what countries are going to be able to pat $100K per year for expensive drugs ? ALL countries are going to be saddled with MASSIVE debts for the next generation Some countries will be bankrupt by Covid -19 buywell sees the world having to press the reset button dyor | buywell3 | |
02/4/2020 14:05 | TM - actives for patented drugs would almost always be produced by the drug company concerned - that is where the margin is pushed to lower group taxes. I suspect that the comment above related to the actives for low margin generics. Not to say that those drugs themselves are not important to patients. | alphorn | |
02/4/2020 13:59 | Retailers hiked the price of cough and cold medicines by 10.7% last week according to a snapshot analysis of the impact of coronavirus on the economy. Data from the Office for National Statistics (ONS) using online prices set by a number of UK retailers showed the sharp increase for the week ending 29 March compared to the week before. | tradermichael | |
02/4/2020 13:45 | "TraderMichael2 Apr '20 - 11:43 - 21058 of 21063 Which API's exactly?" Presumably the ones India cannot source from China! India has stopped exporting API's as well | crossing_the_rubicon | |
02/4/2020 13:15 | Understand that - just felt given the news about Banks and divis there would be movement this way. Companies like IMB are up which are also defensive | watfordhornet | |
02/4/2020 13:14 | Corona virus is the biggest risk so far. | abdullla |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions